Dedicated to Providing Hope through Comprehensive Care.
Skip to main content

Decoding HER2/neu in Breast Cancer: Unraveling the Mystery for Better Outcomes  

HER2/neu: A Vital Piece of the Puzzle

HER2/neu, short for Human Epidermal Growth Factor Receptor 2, is a protein that, when overexpressed in breast cancer cells, can drive uncontrolled cell growth. In simpler terms, it's like a switch that, when turned on excessively, accelerates the growth and division of cancer cells.

Why Does HER2 Matter?

The presence of HER2/neu can significantly influence the behavior of breast cancer. Tumors that overexpress HER2/neu are often more aggressive and have a higher likelihood of recurrence. However, this knowledge is empowering rather than discouraging because it opens doors to targeted therapies specifically designed to counteract the effects of HER2/neu.

The Role of HER2 Testing

Identifying whether a breast cancer patient's tumor overexpresses HER2/neu is a critical step in the diagnostic process. HER2 testing is typically done through immunohistochemistry (IHC) or fluorescence in situ hybridization (FISH). These tests help categorize breast cancer into subtypes, guiding treatment decisions.

Targeting HER2: A Revolution in Breast Cancer Treatment

The discovery of HER2/neu overexpression led to groundbreaking advancements in breast cancer treatment. Targeted therapies, such as trastuzumab (Herceptin), pertuzumab, and ado-trastuzumab emtansine (Kadcyla), have demonstrated remarkable success in improving outcomes for patients with HER2-positive breast cancer.

Individualized Treatment Plans

For patients diagnosed with HER2-positive breast cancer, the treatment landscape is evolving to provide more personalized and effective options. These targeted therapies, often used in combination with traditional treatments like surgery, chemotherapy, or radiation, aim to block the signals of HER2/neu, halting the uncontrolled growth of cancer cells.

The Journey Ahead

As a hematologist-oncologist, I recognize the significance of staying informed and empowered throughout your cancer journey. Advances in understanding HER2/neu and targeted therapies represent a beacon of hope, offering more tailored and effective treatments for patients facing breast cancer.

If you or a loved one has been diagnosed with breast cancer, know that we are here to guide you through the complexities of your treatment options. Each patient is unique, and our commitment is to provide personalized care that addresses the specific characteristics of your cancer.

Stay informed, stay hopeful.

Dr. Nikki Bajaj MD

You Might Also Enjoy...

Empowering Cancer Treatment: The Promise of Immunotherapy

As a physician specializing in Hematology and Oncology, I've had the privilege of witnessing remarkable advancements in cancer treatment. One of the most exciting developments in recent years is immunotherapy. In this blog post, we will explore the concept